EP3810279
A COMBINATION COMPRISING USING AN OLIGOPEPTIDIC COMPOUND AND ANTI-PD-1 OR PD-L1 ANTIBODY FOR USE IN TREATING NEOPLASTIC CONDITIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
19.6.2019EP published:
13.9.2023EP application number:
19734322.1
EPO information:
European Patent Register
Max expiry date:
18.6.2039
Title in English:
A COMBINATION COMPRISING USING AN OLIGOPEPTIDIC COMPOUND AND ANTI-PD-1 OR PD-L1 ANTIBODY FOR USE IN TREATING NEOPLASTIC CONDITIONSLanguage of the patent:
English
Timeline
Today
19.6.2019EP application
13.9.2023EP Publication
Owner
Name:
Cytovation ASAAddress:
Solheimsgaten 11, 5058 Bergen, NO
Inventor
Name:
PRESTEGARDEN, LarsAddress:
5058 Bergen, NO
Priority
Number:
201810058Date:
19.6.2018Country:
GB
Classification
Categories:
A61P 35/00, A61K 38/16, A61K 39/395